MAPT and frontotemporal dementia: In another study, Kim et al. generated patient-specific iPSC lines from two sporadic FTD patients using their PBMCs and investigated the expression of pathological markers, including FTD-tau, transactive response DNA-binding protein 43 (TDP-43), active caspase-3, and fused in sarcoma (FUS) [141].